Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis.


Journal

Theranostics
ISSN: 1838-7640
Titre abrégé: Theranostics
Pays: Australia
ID NLM: 101552395

Informations de publication

Date de publication:
2020
Historique:
received: 17 01 2020
accepted: 06 05 2020
entrez: 10 7 2020
pubmed: 10 7 2020
medline: 4 5 2021
Statut: epublish

Résumé

Intrarenal calcium oxalate (CaOx) crystals induce renal tubular epithelial cells (TECs) injury and inflammation, which involve Toll-like receptor 4 (TLR4)/interferon regulatory factor 1 (IRF1) signaling. Additionally, infiltrating macrophages (Mϕs) might influence intrarenal CaOx crystals and CaOx-induced renal injury. Although the roles of nuclear factor erythroid 2-related factor 2 (Nrf2) in regulating inflammation and macrophage polarization are well characterized, its potential mechanisms in regulating CaOx nephrocalcinosis remain undefined.

Identifiants

pubmed: 32641994
doi: 10.7150/thno.44054
pii: thnov10p7319
pmc: PMC7330860
doi:

Substances chimiques

Interferon Regulatory Factor-1 0
Irf1 protein, mouse 0
Isothiocyanates 0
MicroRNAs 0
Mirn93 microRNA, mouse 0
NF-E2-Related Factor 2 0
Nfe2l2 protein, mouse 0
Sulfoxides 0
Tlr4 protein, mouse 0
Toll-Like Receptor 4 0
Calcium Oxalate 2612HC57YE
sulforaphane GA49J4310U

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7319-7334

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© The author(s).

Déclaration de conflit d'intérêts

Competing Interests: The authors have declared that no competing interest exists.

Références

Nat Rev Immunol. 2011 Oct 25;11(11):750-61
pubmed: 22025054
Front Immunol. 2018 Mar 29;9:619
pubmed: 29651290
Theranostics. 2019 Jan 1;9(2):405-423
pubmed: 30809283
J Urol. 2014 Jun;191(6):1906-12
pubmed: 24518782
Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2849-54
pubmed: 17293456
J Bone Miner Res. 2009 May;24(5):908-24
pubmed: 19113933
Cell Death Differ. 2018 Mar;25(3):486-541
pubmed: 29362479
J Cell Biochem. 2019 Mar;120(3):2847-2858
pubmed: 29232002
J Am Soc Nephrol. 2019 Oct;30(10):1857-1869
pubmed: 31296606
Sci Rep. 2017 May 11;7(1):1798
pubmed: 28496123
Glia. 2009 Apr 15;57(6):645-56
pubmed: 18942756
Molecules. 2019 Oct 16;24(20):
pubmed: 31623197
Annu Rev Pharmacol Toxicol. 2007;47:89-116
pubmed: 16968214
Cell Death Dis. 2014 Dec 11;5:e1562
pubmed: 25501823
Theranostics. 2018 Oct 22;8(19):5348-5361
pubmed: 30555551
Nature. 2016 Aug 25;536(7617):446-50
pubmed: 27501150
Free Radic Biol Med. 2018 Jun;121:78-85
pubmed: 29678610
Nat Commun. 2016 Jan 28;7:10274
pubmed: 26817517
J Cell Biochem. 2018 Dec 12;:
pubmed: 30548662
Cell Commun Signal. 2018 Sep 4;16(1):54
pubmed: 30180849
Transl Androl Urol. 2014 Sep 1;3(3):256-276
pubmed: 25383321
Nephrol Dial Transplant. 2014 Mar;29(3):507-14
pubmed: 24163269
Sci Rep. 2017 Aug 3;7(1):7250
pubmed: 28775336
Sci Rep. 2016 Oct 12;6:35167
pubmed: 27731368
Mol Immunol. 2007 Jan;44(4):338-46
pubmed: 16597464
Cell. 2010 Mar 19;140(6):805-20
pubmed: 20303872
J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Dec 5;781(1-2):433-55
pubmed: 12450673
BJU Int. 2017 Jul;120(1):109-116
pubmed: 28236332
J Bone Miner Res. 2010 Dec;25(12):2701-11
pubmed: 20577968
J Histochem Cytochem. 1964 May;12:333-6
pubmed: 14193854
EBioMedicine. 2019 Dec;50:366-378
pubmed: 31735555
Mol Immunol. 2016 Sep;77:205-12
pubmed: 27541693
Front Immunol. 2018 Sep 25;9:2173
pubmed: 30319631
N Engl J Med. 2013 Aug 15;369(7):649-58
pubmed: 23944302
Am J Physiol. 1989 Jul;257(1 Pt 2):F99-106
pubmed: 2750929
J Immunol. 2014 Mar 15;192(6):2837-45
pubmed: 24554772
J Am Soc Nephrol. 2014 Aug;25(8):1680-97
pubmed: 24578130
J Urol. 2015 Dec;194(6):1787-96
pubmed: 26192255
Pharmacol Res. 2016 Sep;111:509-522
pubmed: 27431331
J Am Soc Nephrol. 1999 Nov;10(11):2323-31
pubmed: 10541291
J Proteome Res. 2012 Jun 1;11(6):3269-80
pubmed: 22512661
Trends Immunol. 2004 Dec;25(12):677-86
pubmed: 15530839
Clin Chim Acta. 2006 May;367(1-2):120-31
pubmed: 16458875
Exp Neurol. 2013 Dec;250:239-49
pubmed: 24120440
Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):426-30
pubmed: 1729712
Kidney Int Suppl (2011). 2014 Nov;4(1):34-38
pubmed: 26312148
Sci Rep. 2017 Mar 16;7:44612
pubmed: 28300213
J Bone Miner Res. 1995 Dec;10(12):1913-29
pubmed: 8619372
Kidney Int. 2017 Mar;91(3):587-602
pubmed: 28017324
Adv Chronic Kidney Dis. 2017 Mar;24(2):57-63
pubmed: 28284380
Urol Res. 2007 Apr;35(2):89-99
pubmed: 17393196
J Clin Invest. 2013 Jan;123(1):236-46
pubmed: 23221343
Kidney Dis (Basel). 2018 Jun;4(2):49-57
pubmed: 29998119
Pediatr Nephrol. 2010 May;25(5):831-41
pubmed: 19198886
Int Immunopharmacol. 2017 May;46:156-162
pubmed: 28284149
Clin Nucl Med. 2017 Feb;42(2):112-113
pubmed: 27879491
Nat Rev Nephrol. 2019 Apr;15(4):220-239
pubmed: 30651611
Trends Mol Med. 2012 Jun;18(6):337-47
pubmed: 22578879
J Immunol Res. 2018 Jan 14;2018:8917804
pubmed: 29507865
J Am Soc Nephrol. 2017 Mar;28(3):761-768
pubmed: 27612997
J Nucl Med. 2001 Oct;42(10):1551-5
pubmed: 11585872
Am J Physiol Renal Physiol. 2019 Jul 1;317(1):F137-F151
pubmed: 31091119
Sci Rep. 2016 Jul 01;6:28808
pubmed: 27363348
Front Immunol. 2019 Apr 17;10:799
pubmed: 31057539
Kidney Int. 2019 Mar;95(3):540-562
pubmed: 30712922
J Am Soc Nephrol. 2005 Jul;16(7):1904-8
pubmed: 15930089
J Transl Med. 2018 Sep 17;16(1):257
pubmed: 30223848
Nat Rev Dis Primers. 2016 Feb 25;2:16008
pubmed: 27188687
Biochem Biophys Res Commun. 2018 Jun 7;500(3):790-796
pubmed: 29684352
Nat Rev Nephrol. 2017 Apr;13(4):226-240
pubmed: 28218266
FASEB J. 2016 Oct;30(10):3368-3377
pubmed: 27358390

Auteurs

Haoran Liu (H)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.

Xiaoqi Yang (X)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Kun Tang (K)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Tao Ye (T)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Chen Duan (C)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Peng Lv (P)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Libin Yan (L)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Xiaoliang Wu (X)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Zhiqiang Chen (Z)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Jianhe Liu (J)

Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.

Yaoliang Deng (Y)

Department of Urology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

Guohua Zeng (G)

Department of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Jinchun Xing (J)

Department of Urology, The First Affiliated Hospital of Xiamen University, Xiamen, China.

Zhangqun Ye (Z)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Hua Xu (H)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH